340450 — GC Genome Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for GC Genome, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,637	8,637	6,528	40,118
Net Total Accounts Receivable
Net Total Receivables	4,546	4,437	5,503	8,332
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	24,120	14,550	13,663	50,970
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18,094	18,759	14,918	12,254
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	48,896	42,819	40,622	84,627
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,393	12,978	3,199	2,741
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	22,311	17,772	7,543	6,354
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	26,585	25,048	33,080	78,273
Total Liabilities & Shareholders' Equity	48,896	42,819	40,622	84,627
Total Common Shares Outstanding